Distribution of α-Galactosidase A in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant α-Galactosidase A in Fabry Mice

重组DNA 分布(数学) α-半乳糖苷酶 法布里病 肾 内分泌学 内科学 医学 化学 生物化学 数学 数学分析 基因 疾病
作者
Erik Christensen,Qun Zhou,Søren Schwartz Sørensen,A[Combining Ring Above]se K. Rasmussen,Christian Borch Jacobsen,Ulla Feldt‐Rasmussen,Rikke Nielsen
出处
期刊:Journal of The American Society of Nephrology [American Society of Nephrology]
卷期号:18 (3): 698-706 被引量:46
标识
DOI:10.1681/asn.2006080822
摘要

Deficiency of lysosomal alpha-galactosidase A (alpha-Gal A) in Fabry disease results in cellular accumulation of globotriaosylceramide (Gl3), often leading to end-stage renal failure. Gl3 accumulates in endothelial, glomerular, and tubular cells. Replacement therapy with recombinant alpha-Gal A to some extent reduces cellular accumulation of Gl3 in the kidney. This study shows high lysosomal expression of alpha-Gal A in all tubular segments and interstitial cells of normal human kidney. However, glomeruli and endothelial cells did not express the enzyme to any significant extent. Recombinant enzyme was taken up by rat yolk sac cells in a receptor-associated protein-inhibitive manner, and surface plasmon resonance experiments revealed binding to megalin, indicating a possible mechanism for uptake of alpha-Gal A in the tubular cells. After infusion into experimental animals or patients, alpha-Gal A was recovered in the urine, indicating glomerular filtration. Recombinant alpha-Gal A was also found in kidneys of normal and alpha-Gal A knockout mice by Western blotting and localized to endosomes and lysosomes in proximal tubules, interstitial cells, and glomerular podocytes by immunocytochemistry and autoradiography but not in vascular endothelial cells. In conclusion, intravenously administered enzyme is taken up by interstitial cells, is to some extent filtered in glomeruli, and is taken up by podocytes and reabsorbed by receptor-mediated endocytosis in proximal tubule cells, directly indicating a potential beneficial effect of enzyme replacement therapy for these cells.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
浮云发布了新的文献求助10
刚刚
tianfx3完成签到,获得积分10
1秒前
1秒前
603完成签到,获得积分10
1秒前
英俊的铭的应助被Sheryl采纳,获得10
2秒前
luo关注了科研通微信公众号
3秒前
Czz发布了新的文献求助10
4秒前
orixero的应助被Lin采纳,获得10
4秒前
打打的应助被爱吃肉肉的蚂蚁采纳,获得10
4秒前
CHENG_2025发布了新的文献求助10
5秒前
coolru的应助被Denmark采纳,获得10
5秒前
Lkyt2026完成签到,获得积分10
7秒前
李爱国的应助被558863采纳,获得10
7秒前
科研通AI2S的应助被xinling采纳,获得10
8秒前
袁瑞完成签到,获得积分10
8秒前
8秒前
李爱国的应助被AA采纳,获得10
8秒前
molihuakai的应助被e00ec采纳,获得10
9秒前
9秒前
9秒前
coolru的应助被忐忑的远望采纳,获得10
9秒前
10秒前
要吃虾饺完成签到,获得积分10
11秒前
Maestro_S的应助被美丽冬卉采纳,获得10
11秒前
科研通AI6.4的应助被美丽冬卉采纳,获得10
11秒前
斯文败类的应助被美丽冬卉采纳,获得10
11秒前
12秒前
大意的绿蕊完成签到,获得积分20
12秒前
13秒前
orixero的应助被ttttTTTT采纳,获得10
13秒前
汪洋完成签到,获得积分10
13秒前
Lin完成签到,获得积分10
13秒前
科研通AI6.3的应助被GamAooL采纳,获得10
14秒前
14秒前
活佛济公发布了新的文献求助10
14秒前
14秒前
jjqzju完成签到,获得积分10
15秒前
daomaihu发布了新的文献求助100
15秒前
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175267
求助须知:如何正确求助?哪些是违规求助? 9567035
关于积分的说明 21789830
捐赠科研通 7769741
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556149
邀请新用户注册赠送积分活动 2477241